SlideShare a Scribd company logo
1 of 17
1
Dakota Drug Sales Meeting
The Past & The Future
March 24, 2016
2
Nipro Diagnostics Changes
• Home Diagnostics Sold to Nipro Corporation February 2010
• Nipro Corporation sells diabetes unit to Sinocare Health
January 7, 2016
• New names announced for the diabetes unit February 1,
2016 now Trividia Health
• Manufacturing to remain in Ft Lauderdale, FL, with circuitry
still manufactured in Formosa
• Sinocare is new to the US market currently has @ 40% of the
Chinese bgm market.
3
DAK Drug Sales TRUE Test Units 2014
• Q1 2014 3,798 vials
• Q2 2014 5,225 vials
• Q3 2014 5,646 vials
• Q4 2014 3,726 vials
• Total units for 2014
18,396
4
DAK Drug Sales TRUE Test Units 2015
• Q1 2015 6,208 units
• Q2 2015 5,466 units
• Q3 2015 6,018 units
• Q4 2015 4,872 units
• Total units for 2015
22,564
5
Sales Growth 2015
• 2014 Total units 18,396
• 2015 Total units 23,588
Percent Growth
22%
6
Diabetes Testing Market US - Dollars
Gross Dollar Sales Test Strips
• Roche -16%
• Lifescan -10%
• Abbott - 3%
• Bayer* - 3%
*Sold to Panasonic & KKR June 2015 new name Ascensia.
7
Diabetes Testing Market Units 2015
Unit sales 2014 vs 2015
Lifescan +10%
Roche - 3%
Abbott + 7%
Bayer + 4%
Trividia Health + 4%
8
9
Diabetic Testing Payer Sources
• Commercial insurance 47%
• Medicare B 16%
• Medicare D 16%
• Managed Medicaid 13%
• FFS Medicaid 5%
• Cash 3%
10
Diabetic Testing Market Trends
• New diabetic population continues to grow
• Diabetics testing appears flat if measured by sales
• CMS changes in Med B 3 years ago reduced the number of
testers
• In some cases retail pharmacies have chosen to give strips
away in order to retain pateints
11
Market Place Changes
• Infopia announced it is closing effective Feb 2016
• Logimedix closing its testing supply operation effective May 1,
2016
• Prices continue to fall with regard to test strips
• USA Today attacks PBM pricing in an article June 22
• New diabetic population continues to grow
• Diabetic testing is flat according to sales of supplies
• Some stores are giving away testing supplies to retain their
diabetic patient segment
12
Market Disrupter
• CMS changes to Med B nearly 3 years ago impacted retail
store delivery and price
• Effective July 1, 2016 CMS has announced another
reimbursement change form $10.40 per 50 count vial to
$8.32
• It was announced as a bid award for mail order but as last
time to pricing was put in place for retail pharmacy making
claims for Med B diabetes testing supplies
• This change will impact manufacturers, retail operations and
patients
13
Market Disruption = Opportunities
• Pricing on test strips
• Ancillary products/not reimbursed
• Transparency with customers
• Diabetes clubs – circle the wagons
• New products
• Solutions? TBD
• Can I help? Free meters etc
Roger Anderson
847-809-1775 cell
randerson@trividiahealth.com
14
Unsi num duciureribus magnatem
quamet aperum qui et tatusa pel
maximoditae prorpor.
1 Ovidis mos.
2 Sumque si sit et arum.
3 Quo iscideribus.
15
Category Category Category
1.
2.
3.
16
Sales
1st Qtr
2nd Qtr
3rd Qtr
4th Qtr
17
0
1
2
3
4
5
6
Category 1 Category 2 Category 3 Category 4
Series 1
Series 2
Series 3

More Related Content

Similar to Dakota Drug Sales Meeting March 24 2016

5 Ways Your Pharmacy Can Boost Your Revenue Cycle
5 Ways Your Pharmacy Can Boost Your Revenue Cycle5 Ways Your Pharmacy Can Boost Your Revenue Cycle
5 Ways Your Pharmacy Can Boost Your Revenue CycleCompleteRx
 
Federal pharmaceutical pricing reform: What do patients think?
Federal pharmaceutical pricing reform: What do patients think?Federal pharmaceutical pricing reform: What do patients think?
Federal pharmaceutical pricing reform: What do patients think?Canadian Cancer Survivor Network
 
Controlled Substance Prescribing: What to Do?
Controlled Substance Prescribing: What to Do?Controlled Substance Prescribing: What to Do?
Controlled Substance Prescribing: What to Do?RIAPA
 
2017 HEALTHWORKS Employer Seminar [Part 1]: One-on-One Rx: A case study of th...
2017 HEALTHWORKS Employer Seminar [Part 1]: One-on-One Rx: A case study of th...2017 HEALTHWORKS Employer Seminar [Part 1]: One-on-One Rx: A case study of th...
2017 HEALTHWORKS Employer Seminar [Part 1]: One-on-One Rx: A case study of th...HEALTHWORKS by Carolinas Healthcare System
 
Target Pharmacy Services: Health & Wellness
Target Pharmacy Services: Health & WellnessTarget Pharmacy Services: Health & Wellness
Target Pharmacy Services: Health & WellnessTAG Marketing
 
Practical guide to the U.S. physician office laboratory (POL) Part 1
Practical guide to the U.S. physician office laboratory (POL) Part 1Practical guide to the U.S. physician office laboratory (POL) Part 1
Practical guide to the U.S. physician office laboratory (POL) Part 1Rebecca Fein
 
The Role of RWE in Drug Development_4Jun2015_final
The Role of RWE in Drug Development_4Jun2015_finalThe Role of RWE in Drug Development_4Jun2015_final
The Role of RWE in Drug Development_4Jun2015_finalBilly Franks
 
Tga presentation National Medicines Symposium 19 may 2016
Tga presentation National Medicines Symposium 19 may 2016Tga presentation National Medicines Symposium 19 may 2016
Tga presentation National Medicines Symposium 19 may 2016TGA Australia
 
TGA presentation: Update on recent activities
TGA presentation: Update on recent activitiesTGA presentation: Update on recent activities
TGA presentation: Update on recent activitiesTGA Australia
 
Regulatory Reform - an update
Regulatory Reform - an updateRegulatory Reform - an update
Regulatory Reform - an updateTGA Australia
 
Learn-Apply Paradigm to Drug Development
Learn-Apply Paradigm to Drug DevelopmentLearn-Apply Paradigm to Drug Development
Learn-Apply Paradigm to Drug DevelopmentJogaGobburu
 
GLOBAL PHARMACEUTICAL INDUSTRY
GLOBAL PHARMACEUTICAL INDUSTRYGLOBAL PHARMACEUTICAL INDUSTRY
GLOBAL PHARMACEUTICAL INDUSTRYDhanil Francil
 
Hans van Bruggen | Semantic interoperability to manage medicinal data and exc...
Hans van Bruggen | Semantic interoperability to manage medicinal data and exc...Hans van Bruggen | Semantic interoperability to manage medicinal data and exc...
Hans van Bruggen | Semantic interoperability to manage medicinal data and exc...semanticsconference
 
Cadth 2015 c6 panel collab formulary hospital-public plan - eric lun final
Cadth 2015 c6 panel   collab formulary hospital-public plan - eric lun finalCadth 2015 c6 panel   collab formulary hospital-public plan - eric lun final
Cadth 2015 c6 panel collab formulary hospital-public plan - eric lun finalCADTH Symposium
 
HOSPITALFORMULARY.pptx
HOSPITALFORMULARY.pptxHOSPITALFORMULARY.pptx
HOSPITALFORMULARY.pptxPunamGauchan1
 

Similar to Dakota Drug Sales Meeting March 24 2016 (20)

The Cancer Medication Geographical Roulette in Canada
The Cancer Medication Geographical Roulette in CanadaThe Cancer Medication Geographical Roulette in Canada
The Cancer Medication Geographical Roulette in Canada
 
5 Ways Your Pharmacy Can Boost Your Revenue Cycle
5 Ways Your Pharmacy Can Boost Your Revenue Cycle5 Ways Your Pharmacy Can Boost Your Revenue Cycle
5 Ways Your Pharmacy Can Boost Your Revenue Cycle
 
Federal pharmaceutical pricing reform: What do patients think?
Federal pharmaceutical pricing reform: What do patients think?Federal pharmaceutical pricing reform: What do patients think?
Federal pharmaceutical pricing reform: What do patients think?
 
Controlled Substance Prescribing: What to Do?
Controlled Substance Prescribing: What to Do?Controlled Substance Prescribing: What to Do?
Controlled Substance Prescribing: What to Do?
 
2017 HEALTHWORKS Employer Seminar [Part 1]: One-on-One Rx: A case study of th...
2017 HEALTHWORKS Employer Seminar [Part 1]: One-on-One Rx: A case study of th...2017 HEALTHWORKS Employer Seminar [Part 1]: One-on-One Rx: A case study of th...
2017 HEALTHWORKS Employer Seminar [Part 1]: One-on-One Rx: A case study of th...
 
Target Pharmacy Services: Health & Wellness
Target Pharmacy Services: Health & WellnessTarget Pharmacy Services: Health & Wellness
Target Pharmacy Services: Health & Wellness
 
Good Pharmacy Practice.ppt
Good Pharmacy Practice.pptGood Pharmacy Practice.ppt
Good Pharmacy Practice.ppt
 
Pharmacy Week
Pharmacy WeekPharmacy Week
Pharmacy Week
 
Practical guide to the U.S. physician office laboratory (POL) Part 1
Practical guide to the U.S. physician office laboratory (POL) Part 1Practical guide to the U.S. physician office laboratory (POL) Part 1
Practical guide to the U.S. physician office laboratory (POL) Part 1
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
 
The Role of RWE in Drug Development_4Jun2015_final
The Role of RWE in Drug Development_4Jun2015_finalThe Role of RWE in Drug Development_4Jun2015_final
The Role of RWE in Drug Development_4Jun2015_final
 
Tga presentation National Medicines Symposium 19 may 2016
Tga presentation National Medicines Symposium 19 may 2016Tga presentation National Medicines Symposium 19 may 2016
Tga presentation National Medicines Symposium 19 may 2016
 
TGA presentation: Update on recent activities
TGA presentation: Update on recent activitiesTGA presentation: Update on recent activities
TGA presentation: Update on recent activities
 
Regulatory Reform - an update
Regulatory Reform - an updateRegulatory Reform - an update
Regulatory Reform - an update
 
1 product development
1 product development1 product development
1 product development
 
Learn-Apply Paradigm to Drug Development
Learn-Apply Paradigm to Drug DevelopmentLearn-Apply Paradigm to Drug Development
Learn-Apply Paradigm to Drug Development
 
GLOBAL PHARMACEUTICAL INDUSTRY
GLOBAL PHARMACEUTICAL INDUSTRYGLOBAL PHARMACEUTICAL INDUSTRY
GLOBAL PHARMACEUTICAL INDUSTRY
 
Hans van Bruggen | Semantic interoperability to manage medicinal data and exc...
Hans van Bruggen | Semantic interoperability to manage medicinal data and exc...Hans van Bruggen | Semantic interoperability to manage medicinal data and exc...
Hans van Bruggen | Semantic interoperability to manage medicinal data and exc...
 
Cadth 2015 c6 panel collab formulary hospital-public plan - eric lun final
Cadth 2015 c6 panel   collab formulary hospital-public plan - eric lun finalCadth 2015 c6 panel   collab formulary hospital-public plan - eric lun final
Cadth 2015 c6 panel collab formulary hospital-public plan - eric lun final
 
HOSPITALFORMULARY.pptx
HOSPITALFORMULARY.pptxHOSPITALFORMULARY.pptx
HOSPITALFORMULARY.pptx
 

Dakota Drug Sales Meeting March 24 2016

  • 1. 1 Dakota Drug Sales Meeting The Past & The Future March 24, 2016
  • 2. 2 Nipro Diagnostics Changes • Home Diagnostics Sold to Nipro Corporation February 2010 • Nipro Corporation sells diabetes unit to Sinocare Health January 7, 2016 • New names announced for the diabetes unit February 1, 2016 now Trividia Health • Manufacturing to remain in Ft Lauderdale, FL, with circuitry still manufactured in Formosa • Sinocare is new to the US market currently has @ 40% of the Chinese bgm market.
  • 3. 3 DAK Drug Sales TRUE Test Units 2014 • Q1 2014 3,798 vials • Q2 2014 5,225 vials • Q3 2014 5,646 vials • Q4 2014 3,726 vials • Total units for 2014 18,396
  • 4. 4 DAK Drug Sales TRUE Test Units 2015 • Q1 2015 6,208 units • Q2 2015 5,466 units • Q3 2015 6,018 units • Q4 2015 4,872 units • Total units for 2015 22,564
  • 5. 5 Sales Growth 2015 • 2014 Total units 18,396 • 2015 Total units 23,588 Percent Growth 22%
  • 6. 6 Diabetes Testing Market US - Dollars Gross Dollar Sales Test Strips • Roche -16% • Lifescan -10% • Abbott - 3% • Bayer* - 3% *Sold to Panasonic & KKR June 2015 new name Ascensia.
  • 7. 7 Diabetes Testing Market Units 2015 Unit sales 2014 vs 2015 Lifescan +10% Roche - 3% Abbott + 7% Bayer + 4% Trividia Health + 4%
  • 8. 8
  • 9. 9 Diabetic Testing Payer Sources • Commercial insurance 47% • Medicare B 16% • Medicare D 16% • Managed Medicaid 13% • FFS Medicaid 5% • Cash 3%
  • 10. 10 Diabetic Testing Market Trends • New diabetic population continues to grow • Diabetics testing appears flat if measured by sales • CMS changes in Med B 3 years ago reduced the number of testers • In some cases retail pharmacies have chosen to give strips away in order to retain pateints
  • 11. 11 Market Place Changes • Infopia announced it is closing effective Feb 2016 • Logimedix closing its testing supply operation effective May 1, 2016 • Prices continue to fall with regard to test strips • USA Today attacks PBM pricing in an article June 22 • New diabetic population continues to grow • Diabetic testing is flat according to sales of supplies • Some stores are giving away testing supplies to retain their diabetic patient segment
  • 12. 12 Market Disrupter • CMS changes to Med B nearly 3 years ago impacted retail store delivery and price • Effective July 1, 2016 CMS has announced another reimbursement change form $10.40 per 50 count vial to $8.32 • It was announced as a bid award for mail order but as last time to pricing was put in place for retail pharmacy making claims for Med B diabetes testing supplies • This change will impact manufacturers, retail operations and patients
  • 13. 13 Market Disruption = Opportunities • Pricing on test strips • Ancillary products/not reimbursed • Transparency with customers • Diabetes clubs – circle the wagons • New products • Solutions? TBD • Can I help? Free meters etc Roger Anderson 847-809-1775 cell randerson@trividiahealth.com
  • 14. 14 Unsi num duciureribus magnatem quamet aperum qui et tatusa pel maximoditae prorpor. 1 Ovidis mos. 2 Sumque si sit et arum. 3 Quo iscideribus.
  • 17. 17 0 1 2 3 4 5 6 Category 1 Category 2 Category 3 Category 4 Series 1 Series 2 Series 3